Company Filing History:
Years Active: 2009-2010
Title: Maryse Brait: Innovator in Heme Binding Protein Research
Introduction
Maryse Brait is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of biochemistry, particularly in the study of heme binding proteins. With a total of 3 patents, her work has implications for understanding and treating various diseases.
Latest Patents
One of her latest patents is titled "Nucleic acids encoding a heme binding protein polypeptide." This invention relates to methods, reagents, and kits for detecting formyl peptide receptor like-2 (FPRL2) polypeptide activity in a sample. It also identifies agents that modulate this polypeptide activity. Additionally, it includes antibodies raised against FPRL2 and substances aimed at preventing, treating, and alleviating diseases characterized by dysregulation of FPRL2 polypeptide signaling. Another significant patent is "Ligand for G-protein coupled receptor FPRL2," which shares similar methodologies and applications as her previous work.
Career Highlights
Throughout her career, Maryse has worked with notable companies, including Euroscreen S.A. Her innovative research has positioned her as a key figure in her field, contributing to advancements in medical science.
Collaborations
Maryse has collaborated with esteemed colleagues such as Isabelle Migeotte and Marc Parmentier. These partnerships have further enriched her research and expanded the impact of her inventions.
Conclusion
Maryse Brait's contributions to the field of biochemistry through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in understanding heme binding proteins and their applications in medicine.